1 |
Takeda, K., Kaisho, T. and Akira, S. (2003) Toll-like receptors. Annu. Rev. Immunol., 21, 335-376.
DOI
ScienceOn
|
2 |
Dixon, D.R. and Darveau, R.P. (2005) Lipopolysaccharides heterogeneity: innate host responses to bacterial modification of lipid a structure. J. Dent. Res., 84, 584-595.
DOI
ScienceOn
|
3 |
Park, B.S., Song, D.H., Kim, H.M., Choi, B.S., Lee, H. and Lee, J.O. (2009) The structural basis of lipopolysaccharides recognition by the TLR4-MD-2 complex. Nature, 458, 1191-1195.
DOI
ScienceOn
|
4 |
Geng, J., Xiao, S., Zheng, Z., Song, S. and Zhang, L. (2013) Gambogic acid protects from endotoxin shock by suppressing pro-inflammatory factors in vivo and in vitro. Inflammation Res., 62, 165-172.
DOI
ScienceOn
|
5 |
Kim, S.Y., Koo, J.E., Seo, Y.J., Tyagi, N., Jeong, E., Choi, J., Lim, K.M., Park, Z.Y. and Lee, J.Y. (2013) Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2. Br. J. Pharmacol., 168, 1933-1945.
DOI
ScienceOn
|
6 |
Jeong, E., Koo, J.E., Yeon, S.H., Kwak, M.K., Hwang, D.H. and Lee, J.Y. (2014) PPARdelta deficiency disrupts hypoxiamediated tumorigenic potential of colon cancer cells. Mol. Carcinog., 53, 926-937.
DOI
ScienceOn
|
7 |
Lee, J.K., Kim, S.Y., Kim, Y.S., Lee, W.H., Hwang, D.H. and Lee, J.Y. (2009) Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin. Biochem. Pharmacol., 77, 1391-1400.
DOI
ScienceOn
|
8 |
Koo, J.E., Park, Z.Y., Kim, N.D. and Lee, J.Y. (2013) Sulforaphane inhibits the engagement of LPS with TLR4/MD2 complex by preferential binding to Cys133 in MD2. Biochem. Biophys. Res. Commun., 434, 600-605.
DOI
ScienceOn
|
9 |
Fitzgerald, K.A., McWhirter, S.M., Faia, K.L., Rowe, D.C., Latz, E., Golenbock, D.T., Coyle, A.J., Liao, S.M. and Maniatis, T. (2003) IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol., 4, 491-496.
|
10 |
Youn, H.S., Lee, J.Y., Fitzgerald, K.A., Young, H.A., Akira, S. and Hwang, D.H. (2005) Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J. Immunol., 175, 3339-3346.
DOI
|
11 |
Youn, H.S., Lee, J.Y., Saitoh, S.I., Miyake, K., Kang, K.W., Choi, Y.J. and Hwang, D.H. (2006) Suppression of MyD88-and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea. Biochem. Pharmacol., 72, 850-859.
DOI
ScienceOn
|
12 |
Tacconelli, E., Cataldo, M.A., Dancer, S.J., De Angelis, G., Falcone, M., Frank, M., Kahlmeter, G., Pan, A., Petrosillo, N., Rodriguez-Bano, J., Singh, N., Venditti, M., Yokoe, D.S., Cookson, B. and European Society of Clinical, M. (2014) ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin. Microbiol. Infect., 20 Suppl 1, 1-55.
|
13 |
Gudiol, C. and Carratala, J. (2014) Antibiotic resistance in cancer patients. Expert Rev. Anti Infect. Ther., 12, 1003-1016.
DOI
ScienceOn
|
14 |
Klastersky, J., Ameye, L., Maertens, J., Georgala, A., Muanza, F., Aoun, M., Ferrant, A., Rapoport, B., Rolston, K. and Paesmans, M. (2007) Bacteraemia in febrile neutropenic cancer patients. Int. J. Antimicrob. Agents, 30 Suppl 1, S51-59.
DOI
ScienceOn
|